PRESS RELEASE published on 04/24/2023 at 14:02, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
PRESS RELEASE published on 04/24/2023 at 13:59, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 04/21/2023 at 14:04, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
PRESS RELEASE published on 04/21/2023 at 14:02, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
PRESS RELEASE published on 04/21/2023 at 13:59, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 04/20/2023 at 13:53, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 04/19/2023 at 13:42, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE published on 04/19/2023 at 13:38, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
PRESS RELEASE published on 04/19/2023 at 13:34, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 04/18/2023 at 14:10, 2 years 9 months ago Form 8.3 - The Vanguard Group, Inc.: THG plc
Published on 02/06/2026 at 08:00, 4 hours 29 minutes ago Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 03:50, 8 hours 39 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 9 hours 44 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 11 hours 32 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 12 hours 29 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/06/2026 at 11:45, 43 minutes ago Le Conseil d’administration de Sartorius Stedim Biotech S.A. approuve une proposition de dividende de 0,69 euro
Published on 02/06/2026 at 11:45, 43 minutes ago Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros
Published on 02/06/2026 at 11:43, 46 minutes ago The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
Published on 02/06/2026 at 11:26, 1 hour 3 minutes ago CTS EVENTIM: Successful Olympic Premiere for New Arena in Milano
Published on 02/06/2026 at 07:54, 4 hours 34 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
Published on 02/05/2026 at 19:15, 17 hours 14 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 17 hours 14 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
